BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24503096)

  • 1. Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells.
    Yamasaki T; Baron GS; Suzuki A; Hasebe R; Horiuchi M
    Virology; 2014 Feb; 450-451():324-35. PubMed ID: 24503096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells.
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    PLoS One; 2014; 9(9):e106516. PubMed ID: 25181483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane.
    Goold R; McKinnon C; Rabbanian S; Collinge J; Schiavo G; Tabrizi SJ
    J Cell Sci; 2013 Aug; 126(Pt 16):3552-62. PubMed ID: 23813960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cholesterol recycling impairs cellular PrP(Sc) propagation.
    Gilch S; Bach C; Lutzny G; Vorberg I; Schätzl HM
    Cell Mol Life Sci; 2009 Dec; 66(24):3979-91. PubMed ID: 19823766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
    Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
    Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
    Shim SY; Karri S; Law S; Schatzl HM; Gilch S
    Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrograde Transport by Clathrin-Coated Vesicles is Involved in Intracellular Transport of PrP
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    Sci Rep; 2018 Aug; 8(1):12241. PubMed ID: 30115966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an intracellular site of prion conversion.
    Marijanovic Z; Caputo A; Campana V; Zurzolo C
    PLoS Pathog; 2009 May; 5(5):e1000426. PubMed ID: 19424437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.
    Mayer-Sonnenfeld T; Avrahami D; Friedman-Levi Y; Gabizon R
    Cell Mol Neurobiol; 2008 Nov; 28(7):1005-15. PubMed ID: 18350378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.
    Jeffrey M; McGovern G; Sisó S; González L
    Acta Neuropathol; 2011 Jan; 121(1):113-34. PubMed ID: 20532540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
    Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
    Prion; 2015; 9(5):394-403. PubMed ID: 26555211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of intracellular localization of PrP(Sc) in prion-infected cells using a mAb that recognizes the region consisting of aa 119-127 of mouse PrP.
    Yamasaki T; Suzuki A; Shimizu T; Watarai M; Hasebe R; Horiuchi M
    J Gen Virol; 2012 Mar; 93(Pt 3):668-680. PubMed ID: 22090211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
    Pimpinelli F; Lehmann S; Maridonneau-Parini I
    Eur J Neurosci; 2005 Apr; 21(8):2063-72. PubMed ID: 15869502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of small GTPase Rab7 activation in prion infection negatively affects a feedback loop regulating neuronal cholesterol metabolism.
    Cherry P; Lu L; Shim SY; Ebacher V; Tahir W; Schatzl HM; Hannaoui S; Gilch S
    J Biol Chem; 2023 Feb; 299(2):102883. PubMed ID: 36623732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease.
    Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Budka H; Rohwer RG; Baskakov IV
    PLoS Pathog; 2011 Dec; 7(12):e1002419. PubMed ID: 22144901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion aggregates transfer through tunneling nanotubes in endocytic vesicles.
    Zhu S; Victoria GS; Marzo L; Ghosh R; Zurzolo C
    Prion; 2015; 9(2):125-35. PubMed ID: 25996400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
    Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
    J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryo-immunogold electron microscopy for prions: toward identification of a conversion site.
    Godsave SF; Wille H; Kujala P; Latawiec D; DeArmond SJ; Serban A; Prusiner SB; Peters PJ
    J Neurosci; 2008 Nov; 28(47):12489-99. PubMed ID: 19020041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells.
    Magalhães AC; Baron GS; Lee KS; Steele-Mortimer O; Dorward D; Prado MA; Caughey B
    J Neurosci; 2005 May; 25(21):5207-16. PubMed ID: 15917460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.